Gnosis by Lesaffre has expanded its reach for Mood & Cognitive Health solutions in 2023 with a new production line expansion dedicated to its star ingredient: Adonat Premium SAMe (S-Adenosyl-L-Methionine).
SAMe is a natural molecule supporting healthy mood and emotional well-being since it is directly involved in the neurotransmitter’s synthesis. It also sustains cognitive functions, being one of the most important factors studied counteracting alterations in brain structures and functions, intimately tied to the ageing process. Further, SAMe applies to supporting liver and joint health.
An ageing global population, the rise in neurodegenerative diseases, the COVID-19 pandemic, and the most recent phenomenon of digital dementia have amplified consumer demand for SAMe, increasing the traction for brain & mood health solutions. To that end, Gnosis, the key SAMe manufacturer, was motivated to pursue new opportunities for growth and best serve our partners.
“Consumers prioritise their mental well-being,” said Philippe Caillat, Gnosis by Lesaffre’s Global Marketing Director. “That’s what pushed us to continue investing in SAMe to target mood and brain health solutions. Balanced mental health is perceived as equally important as physical health for modern consumers. We’re here to bring to market new solutions with SAMe.”
Epigenetics, longevity, attention, concentration, and stress and anxiety will be new and strategic segments where SAMe can have a predominant role
As a part of the company’s commitment to embracing a customer-centric philosophy, Gnosis is relaunching its Adonat Premium SAMe, completing the ambitious project to expand the SAMe production to fulfil and further enlarge the market. By 2023, the GMP manufacturing operations in Sant’Antonino (CH) – already dedicated to pharmaceutical- and nutraceutical-grade production – will almost double its capacity, to better differentiate Gnosis’ offering and uphold its leadership position as the best SAMe supplier.
Evidence has shown that quality and production expertise represent key features to guarantee ingredient integrity, feeding into product integrity and, therefore, success on the market. For these reasons, Gnosis named its product Adonat Premium SAMe: to stand out from the competitive landscape, because quality is at the centre.
“On top of more traditional fields of application, there is a new set of areas that the scientific community is exploring,” said Caillat. “Epigenetics, longevity, attention, concentration, and stress and anxiety will be new and strategic segments where SAMe can have a predominant role, overcoming new challenges linked to a global population growing fast and getting older, and its future age-related cognitive decline.”
